SCHEMBL3813702

SCHEMBL3813702

CCN(CC)c1ccc(C([O])=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
POLB P06746 3/20 0.56
NOX1 Q9Y5S8 2/20 0.56
GAA P10253 2/20 0.56
MCL1 Q07820 1/20 0.56
ALDH1A1 P00352 8/20 0.52
ALDH3A1 P30838 1/20 0.52
ALDH1A3 P47895 1/20 0.52
KDM4E B2RXH2 1/20 0.51
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
TSHR P16473 2/20 0.50
MAPK1 P28482 2/20 0.50
RECQL P46063 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306139 0.84 MAPT (0.58) MAPTMEN1KMT2APOLBNOX1
SCHEMBL61950 0.84 ALDH1A1 (0.58) MAPTMEN1KMT2APOLBNOX1
SCHEMBL64440 0.83 MEN1 (0.56) MAPTMEN1KMT2APOLBNOX1
SCHEMBL6567199 0.83 MAPT (0.56) MAPTMEN1KMT2APOLBNOX1
Hydrogen Sulfide SCHEMBL6567203 0.83 MAPT (0.56) MAPTMEN1KMT2APOLBNOX1
SCHEMBL181431 0.83 MAPT (0.77) MAPTMEN1KMT2APOLBNOX1
SCHEMBL6569210 0.83 MAPT (0.56) MAPTMEN1KMT2APOLBNOX1
SCHEMBL1477967 0.81 MAPT (0.54) MAPTMEN1KMT2APOLBNOX1
SCHEMBL1066762 0.81 MAPT (0.54) MAPTMEN1KMT2APOLBNOX1
Hydrochloric Acid SCHEMBL2121314 0.81 MAPT (0.54) MAPTMEN1KMT2APOLBNOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9285679-B2 Actinic ray-sensitive or radiation-sensitive composition, and resist film, resist-coated mask blanks, resist pattern forming method and photomask each using the composition FUJIFILM CORPORATION (JP) 2016-03-15 US disclosed
US-20150010855-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, AND RESIST FILM, RESIST-COATED MASK BLANKS, RESIST PATTERN FORMING METHOD AND PHOTOMASK EACH USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2015-01-08 US disclosed
US-20090279168-A1 ADHESIVE COMPOSITION FOR OPTICAL FILTER, OPTICAL FILTER AND DISPLAY DEVICE DAI NIPPON PRINTING CO., LTD. (JP) 2009-11-12 US disclosed
CN-100543022-C 2-furancarboxylic acid hydrazide compound and contain the pharmaceutical composition of this compound DAINIPPON PHARMACEUTICAL CO (JP) 2009-09-23 CN disclosed
US-20090116132-A1 ADHESIVE COMPOSITION FOR OPTICAL FILTER, OPTICAL FILTER AND DISPLAY DEVICE DAI NIPPON PRINTING CO., LTD. (JP) 2009-05-07 US disclosed
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20060121392-A1 Optical filter and display using the same DAI NIPPON PRINTING CO., LTD. (JP) 2006-06-08 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
CN-1628111-A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO (JP) 2005-06-15 CN disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed
EP-0782164-B1 Plasma display filter MITSUI CHEMICALS INC (JP) 2002-04-10 EP disclosed
US-5804102-A USE OF METAL COMPLEXES TO CUT OFF NEAR INFRARED RAYS; PREVENTION OF INTERFERENCE BETWEEN TELEVISION AND OTHER REMOTE CONTROLLED ELECTRONICS MITSUI CHEMICALS, INC. (JP) 1998-09-08 US disclosed
EP-0782164-A1 Plasma display filter MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1997-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 MAPT 4833/4885MEN1 1481/4885KMT2A 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.